Patents by Inventor Kathryn M. Albers

Kathryn M. Albers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use
    Patent number: 5859311
    Abstract: Transgenic mice express increased levels of neurotrophin-3 (NT-3) in epithelium when their ancestors are microinjected with the NT-3 gene. The NT-3 growth factor expressing transgenic mice are useful in the study of neurodegenerative disorders of the brain such as Parkinson's syndrome and Alzheimer's disease, of the spinal cord motor neurons such as amyotrophic lateral sclerosis, and for testing drug candidates for the treatment of these diseases.
    Type: Grant
    Filed: November 27, 1995
    Date of Patent: January 12, 1999
    Assignee: University of Kentucky Research Foundation
    Inventors: Kathryn M. Albers, Brian M. Davis
  • Transgenic mice which overexpress nerve growth factor
    Patent number: 5602309
    Abstract: Transgenic mice that express increased levels of nerve growth factor (NGF) in the epidermis and other stratified, keratinized epithelium. The nerve growth factor expressing transgenic mice are useful in the study of neurodegenerative disorders of the brain such as Parkinson's syndrome and Alzheimer's disease and for testing for drug candidates for the treatment of these diseases.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: February 11, 1997
    Assignee: University of Kentucky Research Foundation
    Inventors: Kathryn M. Albers, Brian M. Davis